Selected research
Market Analysis & Forecast
Global AI Health Detection Market Analysis and Forecast 2026-2032
Market perspective
The global AI Health Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AI Health Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AI Health Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AI Health Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AI Health Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AI Health Detection include Nuvoola, Oatmeal Health, NIRAMAI, iCAD, MultiplAI Health, Medicus AI, AEYE Health, NURA and Kheiron, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AI Health Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AI Health Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Health Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI Health Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Health Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Health Detection revenue, projected growth trends, production technology, application and end-user industry.
AI Health Detection Segment by Company
Nuvoola
Oatmeal Health
NIRAMAI
iCAD
MultiplAI Health
Medicus AI
AEYE Health
NURA
Kheiron
Aidoc
Aiberry
Ellipsis Health
Omdena
Innowise Group
Syndell
Klizo Solutions
Wysa
AI Health Detection Segment by Type
Physical Health
Mental Health
AI Health Detection Segment by Application
Hospital
Enterprise
Individual
Others
AI Health Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Health Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Health Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Health Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Health Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Health Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Health Detection revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Physical Health
- Mental Health
Applications
- Hospital
- Enterprise
- Individual
- Others
Companies covered
- Nuvoola
- Oatmeal Health
- NIRAMAI
- iCAD
- MultiplAI Health
- Medicus AI
- AEYE Health
- NURA
- Kheiron
- Aidoc
- Aiberry
- Ellipsis Health
- Omdena
- Innowise Group
- Syndell
- Klizo Solutions
- Wysa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AI Health Detection Market by Type
- 1.2.1 Global AI Health Detection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Physical Health
- 1.2.3 Mental Health
- 1.3 AI Health Detection Market by Application
- 1.3.1 Global AI Health Detection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Enterprise
- 1.3.4 Individual
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Health Detection Market Dynamics
- 2.1 AI Health Detection Industry Trends
- 2.2 AI Health Detection Industry Drivers
- 2.3 AI Health Detection Industry Opportunities and Challenges
- 2.4 AI Health Detection Industry Restraints
3 Global Growth Perspective
- 3.1 Global AI Health Detection Market Perspective (2021-2032)
- 3.2 Global AI Health Detection Growth Trends by Region
- 3.2.1 Global AI Health Detection Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AI Health Detection Market Size by Region (2021-2026)
- 3.2.3 Global AI Health Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AI Health Detection Revenue by Players
- 4.1.1 Global AI Health Detection Revenue by Players (2021-2026)
- 4.1.2 Global AI Health Detection Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AI Health Detection Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AI Health Detection Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AI Health Detection Key Players Headquarters & Area Served
- 4.4 Global AI Health Detection Players, Product Type & Application
- 4.5 Global AI Health Detection Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AI Health Detection Market CR5 and HHI
- 4.6.3 2025 AI Health Detection Tier 1, Tier 2, and Tier 3
5 AI Health Detection Market Size by Type
- 5.1 Global AI Health Detection Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AI Health Detection Revenue by Type (2021-2032)
- 5.3 Global AI Health Detection Revenue Market Share by Type (2021-2032)
6 AI Health Detection Market Size by Application
- 6.1 Global AI Health Detection Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AI Health Detection Revenue by Application (2021-2032)
- 6.3 Global AI Health Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Nuvoola
- 7.1.1 Nuvoola Company Information
- 7.1.2 Nuvoola Business Overview
- 7.1.3 Nuvoola AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.1.4 Nuvoola AI Health Detection Product Portfolio
- 7.1.5 Nuvoola Recent Developments
- 7.2 Oatmeal Health
- 7.2.1 Oatmeal Health Company Information
- 7.2.2 Oatmeal Health Business Overview
- 7.2.3 Oatmeal Health AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.2.4 Oatmeal Health AI Health Detection Product Portfolio
- 7.2.5 Oatmeal Health Recent Developments
- 7.3 NIRAMAI
- 7.3.1 NIRAMAI Company Information
- 7.3.2 NIRAMAI Business Overview
- 7.3.3 NIRAMAI AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.3.4 NIRAMAI AI Health Detection Product Portfolio
- 7.3.5 NIRAMAI Recent Developments
- 7.4 iCAD
- 7.4.1 iCAD Company Information
- 7.4.2 iCAD Business Overview
- 7.4.3 iCAD AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.4.4 iCAD AI Health Detection Product Portfolio
- 7.4.5 iCAD Recent Developments
- 7.5 MultiplAI Health
- 7.5.1 MultiplAI Health Company Information
- 7.5.2 MultiplAI Health Business Overview
- 7.5.3 MultiplAI Health AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.5.4 MultiplAI Health AI Health Detection Product Portfolio
- 7.5.5 MultiplAI Health Recent Developments
- 7.6 Medicus AI
- 7.6.1 Medicus AI Company Information
- 7.6.2 Medicus AI Business Overview
- 7.6.3 Medicus AI AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.6.4 Medicus AI AI Health Detection Product Portfolio
- 7.6.5 Medicus AI Recent Developments
- 7.7 AEYE Health
- 7.7.1 AEYE Health Company Information
- 7.7.2 AEYE Health Business Overview
- 7.7.3 AEYE Health AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.7.4 AEYE Health AI Health Detection Product Portfolio
- 7.7.5 AEYE Health Recent Developments
- 7.8 NURA
- 7.8.1 NURA Company Information
- 7.8.2 NURA Business Overview
- 7.8.3 NURA AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.8.4 NURA AI Health Detection Product Portfolio
- 7.8.5 NURA Recent Developments
- 7.9 Kheiron
- 7.9.1 Kheiron Company Information
- 7.9.2 Kheiron Business Overview
- 7.9.3 Kheiron AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.9.4 Kheiron AI Health Detection Product Portfolio
- 7.9.5 Kheiron Recent Developments
- 7.10 Aidoc
- 7.10.1 Aidoc Company Information
- 7.10.2 Aidoc Business Overview
- 7.10.3 Aidoc AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.10.4 Aidoc AI Health Detection Product Portfolio
- 7.10.5 Aidoc Recent Developments
- 7.11 Aiberry
- 7.11.1 Aiberry Company Information
- 7.11.2 Aiberry Business Overview
- 7.11.3 Aiberry AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.11.4 Aiberry AI Health Detection Product Portfolio
- 7.11.5 Aiberry Recent Developments
- 7.12 Ellipsis Health
- 7.12.1 Ellipsis Health Company Information
- 7.12.2 Ellipsis Health Business Overview
- 7.12.3 Ellipsis Health AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.12.4 Ellipsis Health AI Health Detection Product Portfolio
- 7.12.5 Ellipsis Health Recent Developments
- 7.13 Omdena
- 7.13.1 Omdena Company Information
- 7.13.2 Omdena Business Overview
- 7.13.3 Omdena AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.13.4 Omdena AI Health Detection Product Portfolio
- 7.13.5 Omdena Recent Developments
- 7.14 Innowise Group
- 7.14.1 Innowise Group Company Information
- 7.14.2 Innowise Group Business Overview
- 7.14.3 Innowise Group AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.14.4 Innowise Group AI Health Detection Product Portfolio
- 7.14.5 Innowise Group Recent Developments
- 7.15 Syndell
- 7.15.1 Syndell Company Information
- 7.15.2 Syndell Business Overview
- 7.15.3 Syndell AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.15.4 Syndell AI Health Detection Product Portfolio
- 7.15.5 Syndell Recent Developments
- 7.16 Klizo Solutions
- 7.16.1 Klizo Solutions Company Information
- 7.16.2 Klizo Solutions Business Overview
- 7.16.3 Klizo Solutions AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.16.4 Klizo Solutions AI Health Detection Product Portfolio
- 7.16.5 Klizo Solutions Recent Developments
- 7.17 Wysa
- 7.17.1 Wysa Company Information
- 7.17.2 Wysa Business Overview
- 7.17.3 Wysa AI Health Detection Revenue and Gross Margin (2021-2026)
- 7.17.4 Wysa AI Health Detection Product Portfolio
- 7.17.5 Wysa Recent Developments
8 North America
- 8.1 North America AI Health Detection Revenue (2021-2032)
- 8.2 North America AI Health Detection Revenue by Type (2021-2032)
- 8.2.1 North America AI Health Detection Revenue by Type (2021-2026)
- 8.2.2 North America AI Health Detection Revenue by Type (2027-2032)
- 8.3 North America AI Health Detection Revenue Share by Type (2021-2032)
- 8.4 North America AI Health Detection Revenue by Application (2021-2032)
- 8.4.1 North America AI Health Detection Revenue by Application (2021-2026)
- 8.4.2 North America AI Health Detection Revenue by Application (2027-2032)
- 8.5 North America AI Health Detection Revenue Share by Application (2021-2032)
- 8.6 North America AI Health Detection Revenue by Country
- 8.6.1 North America AI Health Detection Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AI Health Detection Revenue by Country (2021-2026)
- 8.6.3 North America AI Health Detection Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AI Health Detection Revenue (2021-2032)
- 9.2 Europe AI Health Detection Revenue by Type (2021-2032)
- 9.2.1 Europe AI Health Detection Revenue by Type (2021-2026)
- 9.2.2 Europe AI Health Detection Revenue by Type (2027-2032)
- 9.3 Europe AI Health Detection Revenue Share by Type (2021-2032)
- 9.4 Europe AI Health Detection Revenue by Application (2021-2032)
- 9.4.1 Europe AI Health Detection Revenue by Application (2021-2026)
- 9.4.2 Europe AI Health Detection Revenue by Application (2027-2032)
- 9.5 Europe AI Health Detection Revenue Share by Application (2021-2032)
- 9.6 Europe AI Health Detection Revenue by Country
- 9.6.1 Europe AI Health Detection Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AI Health Detection Revenue by Country (2021-2026)
- 9.6.3 Europe AI Health Detection Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AI Health Detection Revenue (2021-2032)
- 10.2 China AI Health Detection Revenue by Type (2021-2032)
- 10.2.1 China AI Health Detection Revenue by Type (2021-2026)
- 10.2.2 China AI Health Detection Revenue by Type (2027-2032)
- 10.3 China AI Health Detection Revenue Share by Type (2021-2032)
- 10.4 China AI Health Detection Revenue by Application (2021-2032)
- 10.4.1 China AI Health Detection Revenue by Application (2021-2026)
- 10.4.2 China AI Health Detection Revenue by Application (2027-2032)
- 10.5 China AI Health Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AI Health Detection Revenue (2021-2032)
- 11.2 Asia AI Health Detection Revenue by Type (2021-2032)
- 11.2.1 Asia AI Health Detection Revenue by Type (2021-2026)
- 11.2.2 Asia AI Health Detection Revenue by Type (2027-2032)
- 11.3 Asia AI Health Detection Revenue Share by Type (2021-2032)
- 11.4 Asia AI Health Detection Revenue by Application (2021-2032)
- 11.4.1 Asia AI Health Detection Revenue by Application (2021-2026)
- 11.4.2 Asia AI Health Detection Revenue by Application (2027-2032)
- 11.5 Asia AI Health Detection Revenue Share by Application (2021-2032)
- 11.6 Asia AI Health Detection Revenue by Country
- 11.6.1 Asia AI Health Detection Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AI Health Detection Revenue by Country (2021-2026)
- 11.6.3 Asia AI Health Detection Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AI Health Detection Revenue (2021-2032)
- 12.2 SAMEA AI Health Detection Revenue by Type (2021-2032)
- 12.2.1 SAMEA AI Health Detection Revenue by Type (2021-2026)
- 12.2.2 SAMEA AI Health Detection Revenue by Type (2027-2032)
- 12.3 SAMEA AI Health Detection Revenue Share by Type (2021-2032)
- 12.4 SAMEA AI Health Detection Revenue by Application (2021-2032)
- 12.4.1 SAMEA AI Health Detection Revenue by Application (2021-2026)
- 12.4.2 SAMEA AI Health Detection Revenue by Application (2027-2032)
- 12.5 SAMEA AI Health Detection Revenue Share by Application (2021-2032)
- 12.6 SAMEA AI Health Detection Revenue by Country
- 12.6.1 SAMEA AI Health Detection Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AI Health Detection Revenue by Country (2021-2026)
- 12.6.3 SAMEA AI Health Detection Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst